EMM Disclosure

RNS Number:7701G
GoldmanSachs International
29 January 2003

EMM DISCLOSURE
                                                             FORM 38.5 (SUMMARY)

Lodge with a RIS and the Takeover Panel.  Use a separate form for each class of
securities in which dealings have been made.


CONNECTED EXEMPT MARKET- MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS


Name of EMM

Goldman Sachs International




Date of disclosure

29 January 2003



Contact name

Peter Highton




Telephone number

[phone]



Please see attached disclosure of dealings under Rule 38.5 in the securities of
the following companies:

Oxford Glycosciences plc

Cambridge Antibody Technology Group plc



AMENDMENT

If the attached Rule 38.5 disclosure is to amend a previous disclosure, please
state which element(s) of previous disclosure was incorrect:




In the case of option business or dealings in derivatives full details should be
given on a separate sheet so that the nature of the dealings can be fully
understood. For options this should include the number of securities under
option, the exercise period (or in the case of exercise, the exercise date), the
exercise price and any option money paid or received. For derivatives this
should include, at least, the number of reference securities to which they
relate (when relevant), the maturity date (or if applicable the closing out
date) and the reference price.

For full details of the disclosure requirements see Rules 8 and 38 of the Code.
If in doubt contact the Monitoring Section of the Panel, Tel. No: 020 7638 0129.
Email: [e-mail]




                                                                       FORM 38.5

CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS



Dealing in (name of company)

Oxford Glycosciences plc




Class of security

Ordinary Shares




Date of disclosure

29 January 2003



Date of dealing

28 January 2003




Name of EMM

Goldman Sachs International




Name of offeree/offeror with whom connected

Oxford Glycosciences plc



Total number of securities purchased

0



Highest price paid*

0.00 # Sterling



Lowest price paid*

0.00 # Sterling



Total number of securities sold

5,682



Highest price received*

1.75 # Sterling



Lowest price received*

1.75 # Sterling



*Currency must be stated






                                                                       FORM 38.5

CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS



Dealing in (name of company)

Cambridge Antibody Technology Group plc




Class of security

Ordinary Shares




Date of disclosure

29 January 2003



Date of dealing

28 January 2003




Name of EMM

Goldman Sachs International




Name of offeree/offeror with whom connected

Oxford Glycosciences plc



Total number of securities purchased

15,955



Highest price paid*

4.8366 # Sterling



Lowest price paid*

4.8366 # Sterling



Total number of securities sold

0



Highest price received*

0.00 # Sterling



Lowest price received*

0.00 # Sterling



*Currency must be stated



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

EMMSELFEUSDSEFF